CytomX Therapeutics
ID: 5290469A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
2
Funding Rounds
$71.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Da******* | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Se** Mc****** | - | - | - |
| Al** As****** | - | - | - |
| El**** Jo*** | - | - | |
| Ha**** Gi***** |
|
- | |
| Ja*** R. Me**** | - | - | |
| Ma** Mo****** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Se** Mc****** | - | - | - |
Funding series
Funding Series Analysis
The company CytomX Therapeutics has raised a total of $30m in funding over 2 rounds.
Key Insights:
- CytomX Therapeutics Series B round: $30m
- CytomX Therapeutics Series B round August 2012: $41m
Industries
CytomX Therapeutics is active in the following industries: